Senores Pharmaceuticals Limited develops, manufactures, sells, and trades in pharmaceutical and allied products in India, the United States, the United Kingdom, Canada, and internationally. It offers pharmaceutical solutions, such as analgesic/antipyretic, anesthetics and allied products, antibacterial/antibiotic, antiviral, antifungal, antioxidants, antineoplastic, blood line, cardiovascular, neurology, antacid, and vitamin and mineral preparation solutions; and analgesic/anti-inflammatory/antipyretic, anti-diabetic, antimalarial, neutral supplements, and urinary tract generics, as well as management and consultancy services. The company was incorporated in 2017 and is based in Ahmedabad, India.
| Current Price | ₹1,415.95 |
|---|---|
| Market Cap | ₹0 Cr |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals |
| Sub-Industry | Pharmaceuticals > Health Care; Pharmaceuticals, Biotechnology and Life Sciences; Pharmaceuticals; Pharmaceuticals; Pharmaceutical Products; Anti-infective Drugs; Antibiotics; Antifungal Drugs; Antiviral Drugs; Cardiovascular Drugs; Gastrointestinal Drugs |
| P/E Ratio | 53.7 |
| 52-Week Range | ₹601.10 – ₹1,487.90 |
1. Pharmaceuticals-100%
SENORES PHARMACEUTICALS LIMITED is trading at ₹1,415.95, with a market capitalisation of ₹0 Cr.
SENORES PHARMACEUTICALS LIMITED operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Health Care; Pharmaceuticals, Biotechnology and Life Sciences; Pharmaceuticals; Pharmaceuticals; Pharmaceutical Products; Anti-infective Drugs; Antibiotics; Antifungal Drugs; Antiviral Drugs; Cardiovascular Drugs; Gastrointestinal Drugs).
SENORES PHARMACEUTICALS LIMITED has a P/E of 53.7.